Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01 per share
-
Shares outstanding
-
117M
-
Number of holders
-
159
-
Total 13F shares, excl. options
-
73.3M
-
Shares change
-
+11.8M
-
Total reported value, excl. options
-
$1.31B
-
Value change
-
+$165M
-
Put/Call ratio
-
0.07
-
Number of buys
-
105
-
Number of sells
-
-62
-
Price
-
$17.80
Significant Holders of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) as of Q3 2017
198 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share as of Q3 2017.
Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) has 159 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73.3M shares
of 117M outstanding shares and own 62.74% of the company stock.
Largest 10 shareholders include FMR LLC (8.43M shares), JPMORGAN CHASE & CO (7.47M shares), VANGUARD GROUP INC (4.81M shares), BlackRock Inc. (3.41M shares), BLAIR WILLIAM & CO/IL (3.14M shares), ArrowMark Colorado Holdings LLC (2.88M shares), Invesco Ltd. (2.3M shares), COLUMBIA WANGER ASSET MANAGEMENT LLC (2.21M shares), RIVERBRIDGE PARTNERS LLC (2.16M shares), and Partner Fund Management, L.P. (2.06M shares).
This table shows the top 159 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.